Mood Disorders News

Transcendental Meditation, a non-trauma-focused intervention, was noninferior to prolonged exposure therapy in reducing PTSD symptom severity and comorbid depression in veterans with PTSD, according to findings from a randomized controlled trial.

Results from a meta-analysis published in JAMA Psychiatry showed that testosterone may have utility in the adjunct treatment of depressive symptoms in men. However, additional studies are needed to definitively establish efficacy, as well as ideal dosage, according to researchers.

A study published in BMJ found no evidence that mirtazapine added to serotonin-noradrenaline reuptake inhibitors or selective serotonin reuptake inhibitors outperformed placebo among primary care patients with treatment-resistant depression.

ORLANDO, Fla. — Strategies shown to decrease intestinal and blood-brain barrier permeability — like probiotics, prebiotics and supplements such as fish oil — may help subgroups of patients with depression and other psychiatric disorders, according to a presenter here.

ORLANDO, Fla. — An inflammatory perspective on major depressive disorder may help explain certain features of depression, according to a presenter at Psych Congress.

Adolescents who sleep fewer than 8 hours on school nights are more likely to engage in several risk-taking behaviors, according to research published in JAMA Pediatrics. However, teens who get fewer than 6 hours of sleep are at significantly higher risk for considering, planning and attempting suicide, researchers said.

A position paper issued by the European Psychiatric Association supported exercise as a core additional treatment for severe mental illness.

About one-third of first-year college students across eight countries who participated in a self-report WHO survey screened positive for at least one anxiety, mood or substance use disorder, according to research published in the Journal of Abnormal Psychology.

Findings from a systematic review revealed a significant association between early childhood social adversity — including insecure attachment and adversity relating to neglect or abuse — and poorer social cognitive performance in participants with major psychiatric disorders.

Results from a secondary analysis of a placebo-controlled trial demonstrated that Latuda was not tied to treatment-related sexual dysfunction in patients with major depressive disorder and mixed features.